Rein Therapeutics Statistics
Total Valuation
RNTX has a market cap or net worth of $38.71 million. The enterprise value is $25.84 million.
Important Dates
The last earnings date was Monday, April 7, 2025, after market close.
| Earnings Date | Apr 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RNTX has 21.99 million shares outstanding. The number of shares has increased by 290.09% in one year.
| Current Share Class | 21.99M |
| Shares Outstanding | 21.99M |
| Shares Change (YoY) | +290.09% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 18.15% |
| Float | 19.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.38
| Current Ratio | 2.38 |
| Quick Ratio | 2.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.37% and return on invested capital (ROIC) is -23.01%.
| Return on Equity (ROE) | -82.37% |
| Return on Assets (ROA) | -20.89% |
| Return on Invested Capital (ROIC) | -23.01% |
| Return on Capital Employed (ROCE) | -49.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.72M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.10% in the last 52 weeks. The beta is 2.12, so RNTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -64.10% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 48.65 |
| Average Volume (20 Days) | 33,467 |
Short Selling Information
The latest short interest is 156,094, so 0.71% of the outstanding shares have been sold short.
| Short Interest | 156,094 |
| Short Previous Month | 175,001 |
| Short % of Shares Out | 0.71% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 1.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.11M |
| Pretax Income | n/a |
| Net Income | -62.88M |
| EBITDA | -28.05M |
| EBIT | -28.11M |
| Earnings Per Share (EPS) | -$3.51 |
Full Income StatementBalance Sheet
The company has $12.87 million in cash and n/a in debt, giving a net cash position of $12.87 million or $0.58 per share.
| Cash & Cash Equivalents | 12.87M |
| Total Debt | n/a |
| Net Cash | 12.87M |
| Net Cash Per Share | $0.58 |
| Equity (Book Value) | 54.39M |
| Book Value Per Share | 0.43 |
| Working Capital | 7.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -22.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -22.29M |
| FCF Per Share | -$1.01 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |